Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2beb7170-1a2f-49f4-b3d3-c06a6107f3ad
Date 10/14/2015
Company Name 23andMe
Mailing Address 1390 Shorebird Way Mountain View, CA 94043 USA
Company Description 23andMe is focused on empowering individuals to access, explore, and better understand their genetic information, making use of recent advances in DNA analysis technologies and proprietary web-based software tools.
Proceeds Purposes This round of funding will enable us to further our vision for long term growth in our consumer and therapeutic businesses. This investment will enable the company to expand its operations and maximize the potential of its direct-to-consumer product in the US and abroad. The company expects to launch a new user experience that includes carrier status reports in the US, as well as enhanced tools and functionality for customers by the end of the year. The Series E financing will also provide capital for strategic infrastructure including new laboratory space for therapeutic research, a next generation sequencing laboratory as well as other investments in long-term growth.
M&A Terms
Venture Investor Fidelity Management & Research Company